Capillary Biomedical thanks our leading research collaboration and funding partners.
Capillary Biomedical licenses intellectual property from Thomas Jefferson University and collaborates on CSII catheter development.
Capillary Biomedical is supported with funding from JDRF, the leading global organization funding type 1 diabetes research.
Capillary Biomedical has been awarded an SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
Capillary Biomedical has received a $1.5M program related investment in the form of a loan from the Helmsley Charitable Trust for Clinical Trials of New Insulin Infusion Technology